Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-12-014360)

Filing Details

Accession Number:: 0001140361-12-014360
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-09 08:38:41
Reporting Period:: 2012-02-22

Filing Date:: 2012-03-09
Accepted Time:: 2012-03-09 08:38:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
911326	Synageva Biopharma Corp	GEVA	Biological Products, (No Disgnostic Substances) (2836)	561808663

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1111794	R Daniel Tisch	500 Park Avenue New York NY 10022		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-02-22	2,118	$38.90	171,400	No	4	S	Indirect	Through trusts
Common Stock	Disposition	2012-02-29	3,488	$39.19	167,912	No	4	S	Indirect	Through trusts
Common Stock	Disposition	2012-02-29	1,512	$39.19	57,750	No	4	S	Indirect	Through family partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Through trusts
No	4	S	Indirect	Through trusts
No	4	S	Indirect	Through family partnership

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	235,557	Direct
Common Stock	59,262	Indirect	Through family partnership
Common Stock	235,557	Direct